NeoGenomics, Inc. (NEO)
NASDAQ: NEO · Real-Time Price · USD
16.69
+0.10 (0.60%)
Oct 26, 2026, 4:00 PM EDT - Market closed
NeoGenomics Stock Forecast
Stock Price Forecast
According to 12 analysts polled by S&P Global, NeoGenomics stock has a consensus rating of "Buy" and an average price target of $21.85. The average 1-year stock price forecast is 30.92% higher than the current stock price, while the lowest is $16.5 (-1.14%) and the highest is $35 (+109.71%).
Price Target: $21.85 (+30.92%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for NeoGenomics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 6 | 6 | 7 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 4 | 4 | 4 | 4 | 4 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 12 | 12 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bank of America Securities | Bank of America Securities | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Oct 8, 2026 |
| Needham | Needham | Buy Reiterates $19 → $22 | Buy | Reiterates | $19 → $22 | +31.82% | Oct 6, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $21 | Buy | Maintains | $21 | +25.82% | Oct 6, 2026 |
| William Blair | William Blair | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Oct 6, 2026 |
| StoneX | StoneX | Buy Maintains $16 → $20 | Buy | Maintains | $16 → $20 | +19.83% | Oct 6, 2026 |
Financial Forecast
Revenue This Year
805.63M
from 727.33M
Increased by 10.77%
Revenue Next Year
885.66M
from 805.63M
Increased by 9.93%
EPS This Year
0.19
from 0.12
Increased by 56.06%
EPS Next Year
0.34
from 0.19
Increased by 83.01%
EPS and Forward PE are based on non-GAAP adjusted numbers.